Beyond COVID and cancer: In which indications will we see mRNA technology succeed next? And what technological advances might next-generation mRNA platforms offer over those used in the COVID-19 vaccines?
Novartis is teaming up with the NHS to make the PCSK9 inhibitor Leqvio available for UK heart patients who struggle to control their LDL cholesterol with existing drugs.
AI is making strides in cardiology, helping to enable quicker assessment & treatment of strokes, faster nuclear imaging & diagnostic radiology, and earlier detection & monitoring of heart disease.